Dimensional Fund Advisors
SGMT icon

Dimensional Fund Advisors’s Sagimet Biosciences SGMT Stock Holding History

Dimensional Fund Advisors’s Portfolio SGMT Stock Details SGMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.41M Buy
271,217
+135,178
+99% +$753K ﹤0.01% 2774
2025
Q4 		$805K Buy
136,039
+110,705
+437% +$795K ﹤0.01% 2893
2025
Q3 		$174K Hold
25,334
– – ﹤0.01% 3135
2025
Q2 		$193K Hold
25,334
– – ﹤0.01% 3120
2025
Q1 		$82.7K Hold
25,334
– – ﹤0.01% 3221
2024
Q4 		$114K Buy
+25,334
New +$128K ﹤0.01% 3229

Other funds holding SGMT

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Dimensional Fund Advisors's SGMT Position: Q1 2026 in Review

Dimensional Fund Advisors increased its Sagimet Biosciences (SGMT) stake by 99% in Q1 2026, buying an estimated $753K and bringing the position to 271,217 shares worth $1.41M. The position accounts for ﹤0.01% of the portfolio, ranked #2774.

Dimensional Fund Advisors first reported a position in SGMT in Q4 2024 and has held it in 6 quarters since. 88 funds tracked by Wall St. Rank hold SGMT as of Q1 2026.

  • Dimensional Fund Advisors held 271,217 shares of Sagimet Biosciences worth $1.41M as of Q1 2026.
  • Dimensional Fund Advisors bought 135,178 Sagimet Biosciences shares in Q1 2026, an estimated $753K.
  • Sagimet Biosciences made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q1 2026, its #2774 holding.
  • Dimensional Fund Advisors first reported a position in Sagimet Biosciences in Q4 2024 and has held it in 6 quarters since.
  • 88 funds tracked by Wall St. Rank held Sagimet Biosciences as of Q1 2026.

Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.